Artículos de revistas sobre el tema "Glioma Cell Lines"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Glioma Cell Lines".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Chen, Yi-Hsuan, Dueng-Yuan Hueng y Wen-Chiuan Tsai. "Proteolipid Protein 2 Overexpression Indicates Aggressive Tumor Behavior and Adverse Prognosis in Human Gliomas". International Journal of Molecular Sciences 19, n.º 11 (26 de octubre de 2018): 3353. http://dx.doi.org/10.3390/ijms19113353.
Texto completoTuma, Rabiya. "Repopulating glioma cell lines". Journal of Cell Biology 164, n.º 3 (26 de enero de 2004): 334–35. http://dx.doi.org/10.1083/jcb1643rr2.
Texto completoShi, Fei, Jie Hu, Ping Zheng, Yisong Lv, Hongyu Liu, Guiyun Zhang y Hongyu Jiang. "LncRNA PANTR1 is Associated with Poor Prognostic and Suppresses Apoptosis in Glioma". Journal of Oncology 2023 (20 de febrero de 2023): 1–14. http://dx.doi.org/10.1155/2023/8537036.
Texto completoBota, Daniela A., Daniela Alexandru, Stephen T. Keir, Darell Bigner, James Vredenburgh y Henry S. Friedman. "Proteasome inhibition with bortezomib induces cell death in GBM stem-like cells and temozolomide-resistant glioma cell lines, but stimulates GBM stem-like cells' VEGF production and angiogenesis". Journal of Neurosurgery 119, n.º 6 (diciembre de 2013): 1415–23. http://dx.doi.org/10.3171/2013.7.jns1323.
Texto completoHan, Jizhong, Yu Xiong, Huajiang Deng, Jie Zhou, Lilei Peng, Wei Xiang, Yang Ming y Ligang Chen. "MiR-455-3p regulates glioma cell proliferation by targeting PAX6". Tropical Journal of Pharmaceutical Research 18, n.º 4 (17 de mayo de 2021): 689–95. http://dx.doi.org/10.4314/tjpr.v18i4.2.
Texto completoMatsumoto, Tsuyoshi, Eiichi Tani, Keizo Kaba, Hideki Shindo y Katsuya Miyaji. "Expression of P-glycoprotein in human glioma cell lines and surgical glioma specimens". Journal of Neurosurgery 74, n.º 3 (marzo de 1991): 460–66. http://dx.doi.org/10.3171/jns.1991.74.3.0460.
Texto completoNakano, Atsuhisa, Eiichi Tani, Kaoru Miyazaki, Yoshihiro Yamamoto y Jun-ichi Furuyama. "Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas". Journal of Neurosurgery 83, n.º 2 (agosto de 1995): 298–307. http://dx.doi.org/10.3171/jns.1995.83.2.0298.
Texto completoZhou, You-xin, San-song Chen, Ting-feng Wu, Da-dong Ding, Xiong-hui Chen, Jin-ming Chen, Zuo-peng Su et al. "A Novel Gene RNF138 Expressed in Human Gliomas and Its Function in the Glioma Cell Line U251". Analytical Cellular Pathology 35, n.º 3 (2012): 167–78. http://dx.doi.org/10.1155/2012/519037.
Texto completoAlexiou, George A., Xanthi Xourgia, Evrysthenis Vartholomatos, Spyridon Tsiouris, John A. Kalef-Ezra, Andreas D. Fotopoulos y Athanasios P. Kyritsis. "Comparison of 99mTc-Tetrofosmin and 99mTc-Sestamibi Uptake in Glioma Cell Lines: The Role of P-Glycoprotein Expression". International Journal of Molecular Imaging 2014 (10 de noviembre de 2014): 1–5. http://dx.doi.org/10.1155/2014/471032.
Texto completoJung, Tae-Young, Shin Jung, Hyang-Hwa Ryu, Young-Il Jeong, Yong-Hao Jin, Shu-Guang Jin, In-Young Kim, Sam-Suk Kang y Hyung-Seok Kim. "Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines". Journal of Neurosurgery 109, n.º 2 (agosto de 2008): 273–84. http://dx.doi.org/10.3171/jns/2008/109/8/0273.
Texto completoMiyaji, Katsuya, Eiichi Tani, Hideki Shindo, Atsuhisa Nakano y Takashi Tokunaga. "Effect of tyrphostin on cell growth and tyrosine kinase activity of epidermal growth factor receptor in human gliomas". Journal of Neurosurgery 81, n.º 3 (septiembre de 1994): 411–19. http://dx.doi.org/10.3171/jns.1994.81.3.0411.
Texto completoMuldoon, Daniel, Guisheng Zhao, Carly Batt, Mallika Singh y Theodore Nicolaides. "MODL-17. SHP2 INHIBITORS SHOW ACTIVITY AGAINST NF1-DEFICIENT GLIOMAS AND ENHANCE MAPK PATHWAY INHIBITION IN BRAF-V600E MUTANT GLIOMAS". Neuro-Oncology 22, Supplement_3 (1 de diciembre de 2020): iii414. http://dx.doi.org/10.1093/neuonc/noaa222.591.
Texto completoBowie, Michelle, Seethalakshmi Hariharan, Janell Hostettler, Kristen Roso, Yiping He, Christopher Pirozzi, Martin Roskoski et al. "IMMU-34. ATRX MUTATIONS PREDICT RESPONSE TO INNATE BASED THERAPY IN GLIOMA". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi126. http://dx.doi.org/10.1093/neuonc/noz175.526.
Texto completoWang, Yue, Bingbing Wu, Shengrong Long, QiangLiu y Guangyu Li. "WNK3 promotes the invasiveness of glioma cell lines under hypoxia by inducing the epithelial-to-mesenchymal transition". Translational Neuroscience 12, n.º 1 (1 de enero de 2021): 320–29. http://dx.doi.org/10.1515/tnsci-2020-0180.
Texto completoLi, Ruiting, Yinghui Li, Xin Hu, Haiwei Lian, Lei Wang y Hui Fu. "Transcription factor 3 controls cell proliferation and migration in glioblastoma multiforme cell lines". Biochemistry and Cell Biology 94, n.º 3 (junio de 2016): 247–55. http://dx.doi.org/10.1139/bcb-2015-0162.
Texto completoBaltuch, Gordon H., Nora P. Dooley, William T. Couldwell y Voon Wee Yong. "Staurosporine differentially inhibits glioma versus non-glioma cell lines". Journal of Neuro-Oncology 16, n.º 2 (junio de 1993): 141–47. http://dx.doi.org/10.1007/bf01324701.
Texto completoRakotomalala, Andria, Quentin Bailleul, Clara Savary, Mélanie Arcicasa, Maud Hamadou, Paul Huchedé, Audrey Hochart et al. "H3.3K27M Mutation Controls Cell Growth and Resistance to Therapies in Pediatric Glioma Cell Lines". Cancers 13, n.º 21 (5 de noviembre de 2021): 5551. http://dx.doi.org/10.3390/cancers13215551.
Texto completoWilson, Diana E., Anthony DiGianfilippo, Frank G. Ondrey, Kenning M. Anderson y Jules E. Harris. "Effect of nordihydroguaiaretic acid on cultured rat and human glioma cell proliferation". Journal of Neurosurgery 71, n.º 4 (octubre de 1989): 551–57. http://dx.doi.org/10.3171/jns.1989.71.4.0551.
Texto completoIrvin, David, Hannah Roberts, Vladislav Sharin, Ahsan Farooqi, Sharvari Dharmaiah, Christian Alvarez y Jason Huse. "CSIG-09. ATRX DEFICIENCY IN GLIOMA IMPACTS TRANSCRIPTIONAL PROFILES AND THE IMMUNE MICROENVIRONMENT IN VIVO". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii29. http://dx.doi.org/10.1093/neuonc/noaa215.121.
Texto completoTimerman, Dmitriy y Caleb M. Yeung. "Identity confusion of glioma cell lines". Gene 536, n.º 1 (febrero de 2014): 221–22. http://dx.doi.org/10.1016/j.gene.2013.11.096.
Texto completoHuang, Suning, Gang Chen, Yiwu Dang y Long-Hua Chen. "Overexpression of DcR3 and Its Significance on Tumor Cell Differentiation and Proliferation in Glioma". Scientific World Journal 2014 (2014): 1–7. http://dx.doi.org/10.1155/2014/605236.
Texto completoWild-Bode, Christine, Michael Weller y Wolfgang Wick. "Molecular determinants of glioma cell migration and invasion". Journal of Neurosurgery 94, n.º 6 (junio de 2001): 978–84. http://dx.doi.org/10.3171/jns.2001.94.6.0978.
Texto completoClark, Aaron J., Wagner G. Dos Santos, Jessica Mccready, Mike Y. Chen, Timothy E. Van Meter, Joy L. Ware, Sharon B. Wolber, Helen Fillmore y William C. Broaddus. "Wilms tumor 1 expression in malignant gliomas and correlation of +KTS isoforms with p53 status". Journal of Neurosurgery 107, n.º 3 (septiembre de 2007): 586–92. http://dx.doi.org/10.3171/jns-07/09/0586.
Texto completoVogelbaum, Michael A., Jianxin X. Tong, Rajashri Perugu, David H. Gutmann y Keith M. Rich. "Overexpression of bax in human glioma cell lines". Journal of Neurosurgery 91, n.º 3 (septiembre de 1999): 483–89. http://dx.doi.org/10.3171/jns.1999.91.3.0483.
Texto completoKouchi, Masaaki, Yuki Shibayama, Daisuke Ogawa, Keisuke Miyake, Akira Nishiyama y Takashi Tamiya. "(Pro)renin receptor is crucial for glioma development via the Wnt/β-catenin signaling pathway". Journal of Neurosurgery 127, n.º 4 (octubre de 2017): 819–28. http://dx.doi.org/10.3171/2016.9.jns16431.
Texto completoZhang, Danfeng, Dawei Dai, Mengxia Zhou, Zhenxing Li, Chunhui Wang, Yicheng Lu, Yiming Li y Junyu Wang. "Inhibition of Cyclin D1 Expression in Human Glioblastoma Cells is Associated with Increased Temozolomide Chemosensitivity". Cellular Physiology and Biochemistry 51, n.º 6 (2018): 2496–508. http://dx.doi.org/10.1159/000495920.
Texto completoXi, Yan-Guo, Deng-Peng Ren, Jing-Yun Jin, Lei Zhu, Tai-Long Yi, Xue-Fei Shao, Sheng-Kai Sun, Wen-Bin Zhang y Shi-Xiang Cheng. "Casein Kinase 2 Interacting Protein-1 Suppresses Glioma Cell Proliferation via Regulating the AKT/GSK3β/β-Catenin Pathway". BioMed Research International 2019 (2 de julio de 2019): 1–11. http://dx.doi.org/10.1155/2019/5653212.
Texto completoZhou, Yan, Peter H. Larsen, Chunhai Hao y V. Wee Yong. "CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival". Journal of Biological Chemistry 277, n.º 51 (17 de octubre de 2002): 49481–87. http://dx.doi.org/10.1074/jbc.m206222200.
Texto completoRao, Aparna, Xiaoran Zhang, Christopher Deibert, Paola Sette, Paola Grandi y Nduka Amankulor. "IDH Mutant Gliomas Escape Natural Killer Cell Immune Surveillance by Downregulation of NKG2D Ligand Expression". Journal of Immunology 196, n.º 1_Supplement (1 de mayo de 2016): 142.11. http://dx.doi.org/10.4049/jimmunol.196.supp.142.11.
Texto completoJin, Linchun, Haitao Ge, Changlin Yang, Yu Long, Yifan(Emily) Chang, Luyan Mu, Elias Sayour et al. "CD70 as a novel target of CAR-T-cell therapy for gliomas." Journal of Clinical Oncology 35, n.º 7_suppl (1 de marzo de 2017): 148. http://dx.doi.org/10.1200/jco.2017.35.7_suppl.148.
Texto completoTabatabai, Ghazaleh, Shanmugarajan Krishnan, Ana-Maria Florea, Karl Frei, Kathy Hasenbach, Guido Reifenberger, Niklaus Krayenbuehl, Michael Weller y Hans-Georg Wirsching. "Effect of silencing thymosin beta 4 gene expression on stemness and invasiveness in glioblastoma." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 2081. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2081.
Texto completoQing, Mingjie, Jiahao Zhou, Weijian Chen y Lijuan Cheng. "Highly Expressed CYBRD1 Associated with Glioma Recurrence Regulates the Immune Response of Glioma Cells to Interferon". Evidence-Based Complementary and Alternative Medicine 2021 (16 de julio de 2021): 1–12. http://dx.doi.org/10.1155/2021/2793222.
Texto completoWakabayashi, Toshihiko, Jun Yoshida, Hisao Seo, Kyoto Kazo, Yoshiharu Murata, Nobuo Matsui y Naoki Kageyama. "Characterization of neuroectodermal antigen by a monoclonal antibody and its application in CSF diagnosis of human glioma". Journal of Neurosurgery 68, n.º 3 (marzo de 1988): 449–55. http://dx.doi.org/10.3171/jns.1988.68.3.0449.
Texto completoWang, Zengliang, Yirizhati Aili, Yongxin Wang, Nuersimanguli Maimaitiming, Hu Qin, Wenyu Ji, Guofeng Fan y Bo Li. "The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma". Oxidative Medicine and Cellular Longevity 2022 (9 de agosto de 2022): 1–28. http://dx.doi.org/10.1155/2022/7967722.
Texto completoElahi, Lubayna, Matthew Garrett, Lea Guo, Michael Condro, Riki Kawaguchi, Shwetal Mehta, Albert Lai, Whitney Pope y Harley Kornblum. "CBMT-31. HDAC INHIBITION DIMINISHES THE GROWTH OF ENDOGENOUS IDH MUTANT GLIOMAS". Neuro-Oncology 21, Supplement_6 (noviembre de 2019): vi39—vi40. http://dx.doi.org/10.1093/neuonc/noz175.153.
Texto completoPollack, Ian F., Margaret S. Randall, Matthew P. Kristofik, Robert H. Kelly, Robert G. Selker y Frank T. Vertosick. "Response of malignant glioma cell lines to activation and inhibition of protein kinase C-mediated pathways". Journal of Neurosurgery 73, n.º 1 (julio de 1990): 98–105. http://dx.doi.org/10.3171/jns.1990.73.1.0098.
Texto completoVerheul, C., T. V. Kers, A. Van Der Ploeg, M. Van Der Kaaij, M. Aghababazadeh, M. De Wit, Y. Hoogstrate et al. "P11.47 Generation, characterisation and drug screening of patient-derivedIDH1-mutated glioma cell lines". Neuro-Oncology 21, Supplement_3 (agosto de 2019): iii54. http://dx.doi.org/10.1093/neuonc/noz126.193.
Texto completoZhang, Lei, Eiji Sato, Kenichi Amagasaki, Atsuhito Nakao y Hirofumi Naganuma. "Participation of an abnormality in the transforming growth factor–β signaling pathway in resistance of malignant glioma cells to growth inhibition induced by that factor". Journal of Neurosurgery 105, n.º 1 (julio de 2006): 119–28. http://dx.doi.org/10.3171/jns.2006.105.1.119.
Texto completoCerchia, Laura, Carla Lucia Esposito, Andreas H. Jacobs, Bertrand Tavitian y Vittorio de Franciscis. "Differential SELEX in Human Glioma Cell Lines". PLoS ONE 4, n.º 11 (24 de noviembre de 2009): e7971. http://dx.doi.org/10.1371/journal.pone.0007971.
Texto completoMARK, JOACHIM, BENGT WESTERMARK, JAN PONTÉN y RUNE HUGOSSON. "Banding patterns in human glioma cell lines". Hereditas 87, n.º 2 (12 de febrero de 2009): 243–60. http://dx.doi.org/10.1111/j.1601-5223.1978.tb01267.x.
Texto completode Menezes, Weder Pereira, Viviane Aline Oliveira Silva, Izabela Natália Faria Gomes, Marcela Nunes Rosa, Maria Luisa Corcoll Spina, Adriana Cruvinel Carloni, Ana Laura Vieira Alves et al. "Loss of 5′-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness". Cells 9, n.º 2 (20 de febrero de 2020): 492. http://dx.doi.org/10.3390/cells9020492.
Texto completoSmith, Louise, Sajib Chakraborty, Anbarasu Lourdusamy, Alan McIntyre y Stuart Smith. "The Role of miRNAs in Gliomas in Response to Hypoxia". Neuro-Oncology 24, Supplement_4 (1 de octubre de 2022): iv9. http://dx.doi.org/10.1093/neuonc/noac200.041.
Texto completoKeough, M., K. Shamardani y M. Monje. "P.103 Imaging neuron-glioma cell interactions in freely behaving animals with a novel implantable mini-microscope". Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 50, s2 (junio de 2023): S85. http://dx.doi.org/10.1017/cjn.2023.196.
Texto completoPal, Sangita, Adam Boynton, Ryan Johnston, Naomi Currimjee, Kenin Qian, Mehdi Touat, Charlotte Bellamy et al. "EXTH-95. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS". Neuro-Oncology 24, Supplement_7 (1 de noviembre de 2022): vii231—vii232. http://dx.doi.org/10.1093/neuonc/noac209.893.
Texto completoKashiwagi, Hideki, Yoshihide Hattori, Shinji Kawabata, Ryo Kayama, Kohei Yoshimura, Yusuke Fukuo, Takuya Kanemitsu et al. "Multi-Targeted Neutron Capture Therapy Combined with an 18 kDa Translocator Protein-Targeted Boron Compound Is an Effective Strategy in a Rat Brain Tumor Model". Cancers 15, n.º 4 (6 de febrero de 2023): 1034. http://dx.doi.org/10.3390/cancers15041034.
Texto completoChen, Zhong-ping, Qing-wu Wu y Jing Wang. "Antitumor effect of levetiracetam combined with temozolomide in glioma cell lines." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): e13530-e13530. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e13530.
Texto completoWang, Weijun, Nian-Ling Zhu, Jason Chua, Steve Swenson, Fritz K. Costa, Stephanie Schmitmeier, Barbara A. Sosnowski, Toshiaki Shichinohe, Noriyuki Kasahara y Thomas C. Chen. "Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy". Journal of Neurosurgery 103, n.º 6 (diciembre de 2005): 1058–66. http://dx.doi.org/10.3171/jns.2005.103.6.1058.
Texto completoWang, Tuo, Yan Zhang, Bo Cui, Maode Wang, Ya Li y Ke Gao. "miR-4530 inhibits the malignant biological behaviors of human glioma cells by directly targeting RTEL1". Acta Biochimica et Biophysica Sinica 52, n.º 12 (17 de noviembre de 2020): 1394–403. http://dx.doi.org/10.1093/abbs/gmaa126.
Texto completoPark, Jong-Whi, Felix Sahm, Bianca Steffl, Isabel Arrillaga-Romany, Daniel Cahill, Michelle Monje, Christel Herold-Mende, Wolfgang Wick y Sevin Turcan. "CBIO-20. HIGH LEVELS OF TERT CONFER SENSITIVITY TO THE DNA HYPOMETHYLATING AGENT DECITABINE (DAC) IN GLIOMAS". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi31. http://dx.doi.org/10.1093/neuonc/noab196.120.
Texto completoTamai, Sho, Sabit Hemragul, Jiapaer Shabierjiang, Guangtao Zhang, Jiakang Zhang, Yi Wang, Shingo Tanaka, Masashi Kinoshita, Atsushi Hirao y Mitsutoshi Nakada. "CBMS-12 PENTAMIDINE; TRANSLATIONAL RESEARCH FOR A NEW CHEMOTHERAPY TARGETING ON GLIOMA CELLS AND GLIOMA STEM CELLS USING DRUG REPOSITIONING". Neuro-Oncology Advances 1, Supplement_2 (diciembre de 2019): ii6—ii7. http://dx.doi.org/10.1093/noajnl/vdz039.029.
Texto completo